Marthe A. Kampinga

Intracoronary Versus Intravenous Administration of Abciximab in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention With Thrombus Aspiration

Youlan L. Gu, Marthe A. Kampinga, Wouter G. Wieringa et al. · Circulation · 2010 · 140 citations · Full text

Effect of High-Dose Intracoronary Adenosine Administration During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

Marieke L. Fokkema, Pieter J. Vlaar, Mathijs Vogelzang et al. · Circulation Cardiovascular Interventions · 2009 · 107 citations

Impact of chronic total occlusions on markers of reperfusion, infarct size, and long‐term mortality: A substudy from the TAPAS‐trial

Chris P. H. Lexis, Iwan C.C. van der Horst, Braim M. Rahel et al. · Catheterization and Cardiovascular Interventions · 2010 · 70 citations

Is the Myocardial Blush Grade Scored by the Operator During Primary Percutaneous Coronary Intervention of Prognostic Value in Patients With ST-Elevation Myocardial Infarction in Routine Clinical Practice?

Marthe A. Kampinga, Maarten W. Nijsten, Youlan L. Gu et al. · Circulation Cardiovascular Interventions · 2010 · 30 citations

Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration

Youlan L. Gu, Marieke L. Fokkema, Marthe A. Kampinga et al. · Trials · 2009 · 14 citations · Full text